1. Home
  2. IFBD vs ALZN Comparison

IFBD vs ALZN Comparison

Compare IFBD & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$1.29

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.78

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
ALZN
Founded
2001
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
7.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
IFBD
ALZN
Price
$1.29
$1.78
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $28.00
AVG Volume (30 Days)
★ 425.9K
107.2K
Earning Date
05-01-2023
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 76.77
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.84
52 Week High
$2.18
$2.68

Technical Indicators

Market Signals
Indicator
IFBD
ALZN
Relative Strength Index (RSI) 70.36 62.16
Support Level $0.87 $1.69
Resistance Level $2.18 $2.22
Average True Range (ATR) 0.22 0.08
MACD 0.03 -0.00
Stochastic Oscillator 35.21 70.45

Price Performance

Historical Comparison
IFBD
ALZN

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: